The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000545.6(HNF1A):c.790G>T (p.Val264Phe)

CA214327

36830 (ClinVar)

Gene: HNF1A
Condition: monogenic diabetes
Inheritance Mode: Autosomal dominant inheritance
UUID: 9700d1bf-b8e1-4a24-a0e2-79487ca358fe
Approved on: 2025-08-05
Published on: 2025-08-05

HGVS expressions

NM_000545.6:c.790G>T
NM_000545.6(HNF1A):c.790G>T (p.Val264Phe)
NC_000012.12:g.120994240G>T
CM000674.2:g.120994240G>T
NC_000012.11:g.121432043G>T
CM000674.1:g.121432043G>T
NC_000012.10:g.119916426G>T
NG_011731.2:g.20495G>T
ENST00000560968.6:c.750+40G>T
ENST00000257555.11:c.790G>T
ENST00000257555.10:c.790G>T
ENST00000400024.6:c.790G>T
ENST00000402929.5:n.925G>T
ENST00000535955.5:n.43-3251G>T
ENST00000538626.2:n.191-3251G>T
ENST00000538646.5:c.603G>T
ENST00000540108.1:c.*230G>T
ENST00000541395.5:c.790G>T
ENST00000541924.5:c.713+534G>T
ENST00000543427.5:c.633+614G>T
ENST00000544413.2:c.790G>T
ENST00000544574.5:c.73-2377G>T
ENST00000560968.5:c.893+40G>T
ENST00000615446.4:c.-257-2022G>T
ENST00000617366.4:c.586+661G>T
NM_000545.5:c.790G>T
NM_001306179.1:c.790G>T
NM_000545.8:c.790G>T
NM_001306179.2:c.790G>T
More

Likely Pathogenic

Met criteria codes 4
PM1 PM2_Supporting PP4_Moderate PP3
Not Met criteria codes 2
PS4 PP1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Monogenic Diabetes Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for HNF1A Version 3.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Monogenic Diabetes VCEP
The c.790G>T variant in the HNF1 homeobox A gene, HNF1A, causes an amino acid change of valine to phenylalanine at codon 264 (p.(Val264Phe)) of NM_000545.8. This variant resides in an amino acid within the HNF1α DNA binding domain that directly binds DNA, which is defined as critical for the protein’s function by the ClinGen MDEP (PM1). This variant is absent from gnomAD v2.1.1 and v4.1.0 (PM2_Supporting). Additionally, this variant is predicted to be deleterious by computational evidence, with a REVEL score of 0.964, which is greater than the MDEP VCEP threshold of 0.70 (PP3). This variant was identified in three unrelated individuals with non-autoimmune and non-absolute/near-absolute insulin-deficient diabetes; however, PS4_Moderate cannot be applied because this number is below the ClinGen MDEP threshold (PMID: 18003757, 36257325, internal lab contributors). At least 2 of these individuals did have a clinical history highly specific for HNF1A-MODY (MODY probability calculator result >50%, negative genetic testing for HNF4A, and one had a low renal glucose threshold) (PP4_Moderate; internal lab contributors). This variant segregated with diabetes with one informative meiosis in a single family; however, this does not meet the thresholds for PP1 set by the ClinGen MDEP (PMID: 36257325). In summary, c.790G>T meets the criteria to be classified as likely pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 3.0.0, approved 6/30/2025): PM1, PM2_Supporting, PP3, PP4_Moderate.
Met criteria codes
PM1
This variant resides in an amino acid within the HNF1α DNA binding domain that directly binds DNA, which is defined as critical for the protein’s function by the ClinGen MDEP (PM1).
PM2_Supporting
This variant is absent from gnomAD v2.1.1 and v4.1.0 (PM2_Supporting).
PP4_Moderate
This variant was identified in two individuals with a clinical history highly specific for HNF1A-MODY (MODY probability calculator result >50% and negative genetic testing for HNF4A and one case had low renal glucose theshold) (PP4_Moderate).
PP3
This variant is predicted to be deleterious by computational evidence, with a REVEL score of 0.964, which is greater than the MDEP VCEP threshold of 0.70 (PP3).
Not Met criteria codes
PS4
This variant was identified in three unrelated individuals with non-autoimmune and non-absolute/near-absolute insulin-deficient diabetes; however, PS4_Moderate cannot be applied because this number is below the ClinGen MDEP threshold (PMID: 18003757, 36257325, internal lab contributors).
PP1
This variant segregated with diabetes with one informative meiosis in a single family; however, this does not meet the thresholds for PP1 set by the ClinGen MDEP (internal lab contributors).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.